Testing effectiveness (Phase 2)Study completedNCT02505893What this trial is testingMinimal Islet Transplant at Diabetes OnsetWho this might be right forDiabetes Mellitus, Type 1 Ospedale San Raffaele 6
Testing effectiveness (Phase 2)Study completedNCT00129259What this trial is testingAutoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 DiabetesWho this might be right forDiabetes Mellitus, Type 1 National Institute of Allergy and Infectious Diseases (NIAID) 83
Testing effectiveness (Phase 2)Study completedNCT00947427What this trial is testingCanakinumab Study in Individuals With Newly Diagnosed Type 1 DiabetesWho this might be right forType 1 DiabetesPreservation of Insulin SecretionNewly Diagnosed Type 1 Diabetes+1 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 71
Early research (Phase 1)Study completedNCT03624062What this trial is testingMER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 DiabetesWho this might be right forType 1 Diabetes Mellitus University of Colorado, Denver 21
Testing effectiveness (Phase 2)UnknownNCT04078308What this trial is testingMesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes PatientsWho this might be right forDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Insulin-Dependent Royan Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT07187531What this trial is testingSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesWho this might be right forType 1 Diabetes SAb Biotherapeutics, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT00146484What this trial is testingTwo Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 DiabetesWho this might be right forDiabetes Mellitus, Type 1 Children's Hospital of Eastern Ontario 100
Not applicableStudy completedNCT02867436What this trial is testingThe Effect of Gluten-free Diet on New Onset Type 1 Diabetes (T1D)Who this might be right forType 1 Diabetes University Hospital, Motol 45
Post-approval studies (Phase 4)Study completedNCT01269034What this trial is testingNew Onset Type 1 Diabetes: Role of ExenatideWho this might be right forType 1 Diabetes Albert Einstein College of Medicine 13
Large-scale testing (Phase 3)Not Yet RecruitingNCT07670650What this trial is testingPRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) StudyWho this might be right forType 1 Diabetes (T1D) University of Florida 108
Testing effectiveness (Phase 2)UnknownNCT02763423What this trial is testingAllogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic KetoacidosisWho this might be right forKetoacidosis, Diabetic The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Ended earlyNCT00515099What this trial is testingStudy of Antithymocyte Globulin for Treatment of New-onset T1DMWho this might be right forNew-onset Type 1 Diabetes Mellitus National Institute of Allergy and Infectious Diseases (NIAID) 58
Testing effectiveness (Phase 2)Study completedNCT01341899What this trial is testingEfficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 DiabetesWho this might be right forType 1 Diabetes The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Not applicableStudy completedNCT00357890What this trial is testingInsulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)Who this might be right forDiabetes Mellitus, Insulin-Dependent Nemours Children's Clinic 12
Testing effectiveness (Phase 2)Study completedNCT00100178What this trial is testingNew Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical TrialWho this might be right forDiabetes Mellitus, Type 1 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 126
Testing effectiveness (Phase 2)Ended earlyNCT04899271What this trial is testingAssess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.Who this might be right forNew-onset Type 1 Diabetes Dompé Farmaceutici S.p.A 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05743244What this trial is testingJanus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)Who this might be right forDiabetes Mellitus, Type 1 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 78
Large-scale testing (Phase 3)UnknownNCT01559025What this trial is testingEvaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes MellitusWho this might be right forType 1 DiabetesInsulin Dependent DiabetesJuvenile Onset Diabetes Mellitus+1 more Federal University of São Paulo 44
Not applicableStudy completedNCT00905073What this trial is testingLow Dose Cyclosporin and Methotrexate Therapy in DiabetesWho this might be right forType 1 Diabetes Mellitus Georgetown University 8
Testing effectiveness (Phase 2)Study completedNCT00529191What this trial is testingAtorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)Who this might be right forType 1 Diabetes Children's Hospital of Philadelphia 40